Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients
NCT05667324Phase 4Completed
- Sponsor
- University of Florida
- Start
- Apr 2023
- Primary completion
- Feb 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by University of Florida. Primary endpoint: Post Operative Pain Scores at 5 days. Started Apr 2023; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05667324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05667324.